Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cognoa Seeks De Novo Clearance For AI-Powered Diagnostic App For Autism After Successful Study

Executive Summary

FDA clearance of the ASD Diagnostic app could lead to early diagnosis, improving quality of life of children with ASD and their caregivers. 

You may also be interested in...



Device Week, 25 September 2020 – Cognoa Develops Autism Detector; Longitude Launches New Fund

This episode of our weekly podcast covers Cognoa’s development of an app to detect autism spectrum disorder early, Novocure’s customer-focused business strategy during the pandemic, and the new $585m fund created by Longitude Capital to invest in medtech, pharma and biotech.

FDA Gives Insight On Changing Approval Landscape

Device center officials at the US agency focused on new approval pathways at RAPS Convergence 2020.

The Top 5 Start-Up Spotlight Stories In 2019: Two Pore Guys, Distalmotion, SetPoint, Innovative Cardiovascular Solutions, Cognoa

A look back at Medtech Insight's five most-read Start-Up Spotlight stories in 2019 pointed to diverse interests among our readers – handheld sensor technology, a bioelectric implant, vagus nerve stimulation, embolic protector for TAVR and digital diagnostics.

Related Content

Topics

UsernamePublicRestriction

Register

LL1121650

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel